GOLDMAN SACHS GROUP INC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$22,000
-29.0%
19,308
-8.6%
0.00%
Q2 2022$31,000
-63.1%
21,127
-41.9%
0.00%
Q1 2022$84,000
-61.6%
36,346
-54.3%
0.00%
Q4 2021$219,000
-22.1%
79,462
+69.7%
0.00%
Q3 2021$281,000
+242.7%
46,816
+179.2%
0.00%
Q2 2021$82,000
-31.1%
16,766
-86.3%
0.00%
Q2 2019$119,000
+376.0%
122,080
+416.3%
0.00%
Q4 2018$25,000
-93.3%
23,646
-60.8%
0.00%
Q3 2018$371,000
+1.6%
60,256
+76.8%
0.00%
Q2 2018$365,000
-28.0%
34,077
-27.8%
0.00%
Q1 2018$507,000
+52.7%
47,206
-0.4%
0.00%
Q4 2017$332,000
+3.4%
47,378
+29.2%
0.00%
Q3 2017$321,000
+0.9%
36,671
+5.1%
0.00%
Q2 2017$318,000
-8.6%
34,888
-20.4%
0.00%
Q1 2017$348,000
+18.4%
43,852
+33.4%
0.00%
Q4 2016$294,000
+16.7%
32,880
-8.7%
0.00%
Q2 2016$252,00036,0000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders